Stocks
Globus Medical Financial Statements (GMED) |
||||||||||
| Globus Medicalsmart-lab.ru | % | 2021 | 2022 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 17.02.2022 | 31.12.2022 | 21.02.2023 | 16.03.2023 | 21.02.2024 | 05.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 958.1 | 1 023 | 1 023 | 1 023 | 1 568 | 2 479 | |||
| Operating Income, bln rub | 172.0 | 236.3 | 228.0 | 228.0 | 133.1 | 164.5 | ||||
| EBITDA, bln rub | ? | 250.3 | 325.5 | 313.8 | 304.5 | 418.2 | 526.4 | |||
| Net profit, bln rub | ? | 149.2 | 190.2 | 190.2 | 190.2 | 122.9 | 91.5 | |||
| OCF, bln rub | ? | 276.3 | 178.5 | 178.5 | 178.5 | 243.5 | 415.0 | |||
| CAPEX, bln rub | ? | 56.9 | 74.0 | 74.0 | 74.0 | 78.3 | 121.2 | |||
| FCF, bln rub | ? | 219.4 | 104.4 | 104.4 | 104.4 | 165.2 | 293.8 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 524.0 | 522.9 | 522.9 | 522.9 | 887.2 | 1 170 | ||||
| Cost of production, bln rub | 239.2 | 263.7 | 263.7 | 263.7 | 548.2 | 1 127 | ||||
| R&D, bln rub | 97.3 | 73.0 | 73.0 | 73.0 | 124.0 | 170.0 | ||||
| Interest expenses, bln rub | 9.30 | 14.2 | 14.2 | 14.2 | 0.000 | 7.59 | ||||
| Assets, bln rub | 1 957 | 2 076 | 2 076 | 2 076 | 5 086 | 5 086 | ||||
| Net Assets, bln rub | ? | 1 741 | 1 846 | 1 846 | 1 846 | 3 998 | 4 069 | |||
| Debt, bln rub | 5.05 | 0.000 | 6.01 | 6.01 | 520.4 | 534.6 | ||||
| Cash, bln rub | 443.4 | 446.1 | 446.1 | 446.1 | 517.8 | 694.7 | ||||
| Net debt, bln rub | -438.4 | -446.1 | -440.0 | -440.0 | 2.62 | -160.1 | ||||
| Ordinary share price, rub | 72.2 | 74.3 | 74.3 | 74.3 | 53.3 | 46.3 | ||||
| Number of ordinary shares, mln | 100.7 | 100.5 | 100.5 | 100.5 | 113.1 | 135.6 | ||||
| Market cap, bln rub | 7 273 | 7 462 | 7 462 | 7 462 | 6 026 | 6 282 | ||||
| EV, bln rub | ? | 6 835 | 7 016 | 7 022 | 7 022 | 6 029 | 6 122 | |||
| Book value, bln rub | 1 493 | 1 585 | 1 585 | 1 585 | 1 639 | 1 795 | ||||
| EPS, rub | ? | 1.48 | 1.89 | 1.89 | 1.89 | 1.09 | 0.67 | |||
| FCF/share, rub | 2.18 | 1.04 | 1.04 | 1.04 | 1.46 | 2.17 | ||||
| BV/share, rub | 14.8 | 15.8 | 15.8 | 15.8 | 14.5 | 13.2 | ||||
| EBITDA margin, % | ? | 26.1% | 31.8% | 30.7% | 29.8% | 26.7% | 21.2% | |||
| Net margin, % | ? | 15.6% | 18.6% | 18.6% | 18.6% | 7.83% | 3.69% | |||
| FCF yield, % | ? | 3.02% | 1.40% | 1.40% | 1.40% | 2.74% | 4.68% | |||
| ROE, % | ? | 8.57% | 10.3% | 10.3% | 10.3% | 3.07% | 2.25% | |||
| ROA, % | ? | 7.62% | 9.16% | 9.16% | 9.16% | 2.42% | 1.80% | |||
| P/E | ? | 48.7 | 39.2 | 39.2 | 39.2 | 49.0 | 68.6 | |||
| P/FCF | 33.2 | 71.5 | 71.5 | 71.5 | 36.5 | 21.4 | ||||
| P/S | ? | 7.59 | 7.30 | 7.30 | 7.30 | 3.84 | 2.53 | |||
| P/BV | ? | 4.87 | 4.71 | 4.71 | 4.71 | 3.68 | 3.50 | |||
| EV/EBITDA | ? | 27.3 | 21.6 | 22.4 | 23.1 | 14.4 | 11.6 | |||
| Debt/EBITDA | -1.75 | -1.37 | -1.40 | -1.45 | 0.01 | -0.30 | ||||
| R&D/CAPEX, % | 171.1% | 98.6% | 98.6% | 98.6% | 158.4% | 140.3% | ||||
| CAPEX/Revenue, % | 5.94% | 7.24% | 7.24% | 7.24% | 4.99% | 4.89% | ||||
| Globus Medical shareholders | ||||||||||
